Explore

Trendline Trendline
Arrowhead Pharmaceuticals Reveals Positive Data on Plozasiran for Patients with Renal and Hepatic Impairments

Arrowhead Pharmaceuticals Reveals Positive Data on Plozasiran for Patients with Renal and Hepatic Impairments

Arrowhead Pharmaceuticals Reveals Positive Data on Plozasiran for Patients with Renal and Hepatic Impairments
Trendline Trendline
Crystalys Therapeutics Initiates Phase 2 Trial for Gout Treatment with Dotinurad

Crystalys Therapeutics Initiates Phase 2 Trial for Gout Treatment with Dotinurad

Crystalys Therapeutics Initiates Phase 2 Trial for Gout Treatment with Dotinurad
Trendline Trendline
Alkermes to Present New Data on Psychiatric Treatments at ASCP Annual Meeting

Alkermes to Present New Data on Psychiatric Treatments at ASCP Annual Meeting

Alkermes to Present New Data on Psychiatric Treatments at ASCP Annual Meeting
Trendline Trendline
Alkermes to Present New Data on Psychiatric and Neurological Disorders at ASCP Meeting

Alkermes to Present New Data on Psychiatric and Neurological Disorders at ASCP Meeting

Alkermes to Present New Data on Psychiatric and Neurological Disorders at ASCP Meeting
Trendline Trendline
Biomunex Partners with AI Firms to Enhance Cancer Immunotherapy Development

Biomunex Partners with AI Firms to Enhance Cancer Immunotherapy Development

Biomunex Partners with AI Firms to Enhance Cancer Immunotherapy Development
Trendline Trendline
PharmaEssentia to Present Clinical Data on Ropeginterferon Alfa-2b for Essential Thrombocythemia at ASCO and EHA 2026

PharmaEssentia to Present Clinical Data on Ropeginterferon Alfa-2b for Essential Thrombocythemia at ASCO and EHA 2026

PharmaEssentia to Present Clinical Data on Ropeginterferon Alfa-2b for Essential Thrombocythemia at ASCO and EHA 2026
Trendline Trendline
Biomunex Partners with AI Companies to Enhance Cancer Immunotherapy Development

Biomunex Partners with AI Companies to Enhance Cancer Immunotherapy Development

Biomunex Partners with AI Companies to Enhance Cancer Immunotherapy Development
Trendline Trendline
IDEAYA Biosciences to Participate in 2026 Jefferies Global Healthcare Conference Highlighting Precision Medicine Advances

IDEAYA Biosciences to Participate in 2026 Jefferies Global Healthcare Conference Highlighting Precision Medicine Advances

IDEAYA Biosciences to Participate in 2026 Jefferies Global Healthcare Conference Highlighting Precision Medicine Advances
Trendline Trendline
Zensulin Supplement Claims Evaluated: Consumer Report Highlights Key Ingredients and Usage

Zensulin Supplement Claims Evaluated: Consumer Report Highlights Key Ingredients and Usage

Zensulin Supplement Claims Evaluated: Consumer Report Highlights Key Ingredients and Usage
Trendline Trendline
Agios Pharmaceuticals Secures EU Approval for PYRUKYND in Thalassaemia Treatment

Agios Pharmaceuticals Secures EU Approval for PYRUKYND in Thalassaemia Treatment

Agios Pharmaceuticals Secures EU Approval for PYRUKYND in Thalassaemia Treatment
Trendline Trendline
Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development

Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development

Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development
Trendline Trendline
Gossamer Bio Faces Securities Class Action Over Study Results

Gossamer Bio Faces Securities Class Action Over Study Results

Gossamer Bio Faces Securities Class Action Over Study Results